Camylofin

DB13738

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 320.477
Wujud -

Peta Jejaring Molekuler
Legenda: Obat • Target • Gen • Enzim • (Panah → menunjukkan arah efek / relasi) • Transporter • Carrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

516 Data
Aclidinium The risk or severity of adverse effects can be increased when Camylofin is combined with Aclidinium.
Mianserin Mianserin may increase the anticholinergic activities of Camylofin.
Mirabegron The risk or severity of urinary retention can be increased when Camylofin is combined with Mirabegron.
Pramlintide The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Camylofin.
Secretin porcine The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Camylofin.
Tiotropium The risk or severity of adverse effects can be increased when Camylofin is combined with Tiotropium.
Topiramate The risk or severity of hyperthermia and oligohydrosis can be increased when Camylofin is combined with Topiramate.
Umeclidinium The risk or severity of adverse effects can be increased when Camylofin is combined with Umeclidinium.
Glycopyrronium The risk or severity of adverse effects can be increased when Camylofin is combined with Glycopyrronium.
Botulinum toxin type A The risk or severity of adverse effects can be increased when Camylofin is combined with Botulinum toxin type A.
Glucagon Camylofin may increase the gastrointestinal motility reducing activities of Glucagon.
Sulpiride Camylofin may increase the anticholinergic activities of Sulpiride.
Botulinum toxin type B The risk or severity of adverse effects can be increased when Camylofin is combined with Botulinum toxin type B.
Eluxadoline The risk or severity of constipation can be increased when Camylofin is combined with Eluxadoline.
Ramosetron The risk or severity of constipation can be increased when Camylofin is combined with Ramosetron.
Naltrexone The risk or severity of adverse effects can be increased when Camylofin is combined with Naltrexone.
Bezitramide The risk or severity of adverse effects can be increased when Camylofin is combined with Bezitramide.
Tramadol The risk or severity of adverse effects can be increased when Camylofin is combined with Tramadol.
Morphine The risk or severity of adverse effects can be increased when Camylofin is combined with Morphine.
Codeine The risk or severity of adverse effects can be increased when Camylofin is combined with Codeine.
Hydromorphone The risk or severity of adverse effects can be increased when Camylofin is combined with Hydromorphone.
Methadone The risk or severity of adverse effects can be increased when Camylofin is combined with Methadone.
Meperidine The risk or severity of adverse effects can be increased when Camylofin is combined with Meperidine.
Oxycodone The risk or severity of adverse effects can be increased when Camylofin is combined with Oxycodone.
Butorphanol The risk or severity of adverse effects can be increased when Camylofin is combined with Butorphanol.
Dextropropoxyphene The risk or severity of adverse effects can be increased when Camylofin is combined with Dextropropoxyphene.
Pentazocine The risk or severity of adverse effects can be increased when Camylofin is combined with Pentazocine.
Sufentanil The risk or severity of adverse effects can be increased when Camylofin is combined with Sufentanil.
Alfentanil The risk or severity of adverse effects can be increased when Camylofin is combined with Alfentanil.
Fentanyl The risk or severity of adverse effects can be increased when Camylofin is combined with Fentanyl.
Nalbuphine The risk or severity of adverse effects can be increased when Camylofin is combined with Nalbuphine.
Levorphanol The risk or severity of adverse effects can be increased when Camylofin is combined with Levorphanol.
Remifentanil The risk or severity of adverse effects can be increased when Camylofin is combined with Remifentanil.
Buprenorphine The risk or severity of adverse effects can be increased when Camylofin is combined with Buprenorphine.
Hydrocodone The risk or severity of adverse effects can be increased when Camylofin is combined with Hydrocodone.
Diphenoxylate The risk or severity of adverse effects can be increased when Camylofin is combined with Diphenoxylate.
Oxymorphone The risk or severity of adverse effects can be increased when Camylofin is combined with Oxymorphone.
Dezocine The risk or severity of adverse effects can be increased when Camylofin is combined with Dezocine.
Levacetylmethadol The risk or severity of adverse effects can be increased when Camylofin is combined with Levacetylmethadol.
Methadyl acetate The risk or severity of adverse effects can be increased when Camylofin is combined with Methadyl acetate.
Dihydroetorphine The risk or severity of adverse effects can be increased when Camylofin is combined with Dihydroetorphine.
Diamorphine The risk or severity of adverse effects can be increased when Camylofin is combined with Diamorphine.
Ethylmorphine The risk or severity of adverse effects can be increased when Camylofin is combined with Ethylmorphine.
Etorphine The risk or severity of adverse effects can be increased when Camylofin is combined with Etorphine.
Dextromoramide The risk or severity of adverse effects can be increased when Camylofin is combined with Dextromoramide.
Desomorphine The risk or severity of adverse effects can be increased when Camylofin is combined with Desomorphine.
Carfentanil The risk or severity of adverse effects can be increased when Camylofin is combined with Carfentanil.
Dihydrocodeine The risk or severity of adverse effects can be increased when Camylofin is combined with Dihydrocodeine.
Alphacetylmethadol The risk or severity of adverse effects can be increased when Camylofin is combined with Alphacetylmethadol.
Dihydromorphine The risk or severity of adverse effects can be increased when Camylofin is combined with Dihydromorphine.
Tapentadol The risk or severity of urinary retention and constipation can be increased when Camylofin is combined with Tapentadol.
Ketobemidone The risk or severity of adverse effects can be increased when Camylofin is combined with Ketobemidone.
DPDPE The risk or severity of adverse effects can be increased when Camylofin is combined with DPDPE.
Lofentanil The risk or severity of adverse effects can be increased when Camylofin is combined with Lofentanil.
Opium The risk or severity of adverse effects can be increased when Camylofin is combined with Opium.
Normethadone The risk or severity of adverse effects can be increased when Camylofin is combined with Normethadone.
Piritramide The risk or severity of adverse effects can be increased when Camylofin is combined with Piritramide.
Alphaprodine The risk or severity of adverse effects can be increased when Camylofin is combined with Alphaprodine.
Nicomorphine The risk or severity of adverse effects can be increased when Camylofin is combined with Nicomorphine.
Meptazinol The risk or severity of adverse effects can be increased when Camylofin is combined with Meptazinol.
Phenoperidine The risk or severity of adverse effects can be increased when Camylofin is combined with Phenoperidine.
Phenazocine The risk or severity of adverse effects can be increased when Camylofin is combined with Phenazocine.
Tilidine The risk or severity of adverse effects can be increased when Camylofin is combined with Tilidine.
Carfentanil, C-11 The risk or severity of adverse effects can be increased when Camylofin is combined with Carfentanil, C-11.
Benzhydrocodone The risk or severity of adverse effects can be increased when Camylofin is combined with Benzhydrocodone.
Naloxegol The risk or severity of adverse effects can be increased when Camylofin is combined with Naloxegol.
Trospium The risk or severity of adverse effects can be increased when Trospium is combined with Camylofin.
Oxyphenonium The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Camylofin.
Benzatropine The risk or severity of adverse effects can be increased when Benzatropine is combined with Camylofin.
Disopyramide The risk or severity of adverse effects can be increased when Disopyramide is combined with Camylofin.
Metixene The risk or severity of adverse effects can be increased when Metixene is combined with Camylofin.
Terfenadine The risk or severity of adverse effects can be increased when Terfenadine is combined with Camylofin.
Buclizine The risk or severity of adverse effects can be increased when Buclizine is combined with Camylofin.
Trihexyphenidyl The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Camylofin.
Oxyphencyclimine The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Camylofin.
Procyclidine The risk or severity of adverse effects can be increased when Procyclidine is combined with Camylofin.
Hyoscyamine The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Camylofin.
Methscopolamine bromide The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Camylofin.
Darifenacin The risk or severity of adverse effects can be increased when Darifenacin is combined with Camylofin.
Tridihexethyl The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Camylofin.
Anisotropine methylbromide The risk or severity of adverse effects can be increased when Anisotropine methylbromide is combined with Camylofin.
Atropine The risk or severity of adverse effects can be increased when Atropine is combined with Camylofin.
Nicardipine The risk or severity of adverse effects can be increased when Nicardipine is combined with Camylofin.
Mecamylamine The risk or severity of adverse effects can be increased when Mecamylamine is combined with Camylofin.
Pirenzepine The risk or severity of adverse effects can be increased when Pirenzepine is combined with Camylofin.
Homatropine methylbromide The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Camylofin.
Benzquinamide The risk or severity of adverse effects can be increased when Benzquinamide is combined with Camylofin.
Propantheline The risk or severity of adverse effects can be increased when Propantheline is combined with Camylofin.
Dicyclomine The risk or severity of adverse effects can be increased when Dicyclomine is combined with Camylofin.
Tropicamide The risk or severity of adverse effects can be increased when Tropicamide is combined with Camylofin.
Cocaine The risk or severity of adverse effects can be increased when Cocaine is combined with Camylofin.
Quinidine The risk or severity of adverse effects can be increased when Quinidine is combined with Camylofin.
Amantadine The risk or severity of adverse effects can be increased when Amantadine is combined with Camylofin.
Methantheline The risk or severity of adverse effects can be increased when Methantheline is combined with Camylofin.
Cycrimine The risk or severity of adverse effects can be increased when Cycrimine is combined with Camylofin.
Cyclopentolate The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Camylofin.
Tolterodine The risk or severity of adverse effects can be increased when Tolterodine is combined with Camylofin.
Oxybutynin The risk or severity of adverse effects can be increased when Oxybutynin is combined with Camylofin.
Pentolinium The risk or severity of adverse effects can be increased when Pentolinium is combined with Camylofin.
Trimethaphan The risk or severity of adverse effects can be increased when Trimethaphan is combined with Camylofin.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul